Literature DB >> 19279016

Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis.

D Daoussis1, V F Panoulas, I Antonopoulos, H John, T E Toms, P Wong, P Nightingale, K M J Douglas, G D Kitas.   

Abstract

OBJECTIVES: The present study aimed to evaluate the prevalence and associations of renal dysfunction in patients with rheumatoid arthritis (RA). It specifically addressed the hypotheses that renal dysfunction in these patients may associate with the presence of insulin resistance, dyslipidaemia, uric acid levels and/or current levels of systemic inflammation.
METHODS: Renal function was assessed by estimated glomerular filtration rate (GFR) using the modification of diet in renal disease equation in 400 consecutive RA patients for this cross-sectional, single-centre study. Risk factors for renal dysfunction were recorded/measured in all participants. Correlations between GFR and other variables were analysed by Pearson or Spearman test as appropriate. Linear regression was used to test the independence of the associations between GFR and other variables.
RESULTS: In this RA patient cohort, 67.75% of patients had a reduced GFR of less than 90 ml/minute per 1.73 m(2) and 12.75% had a GFR of less than 60 ml/minute per 1.73 m(2). Multivariable analysis revealed significant associations between GFR and age (beta = -0.370, p<0.001), female sex (beta = -0.181, p=0.002), total cholesterol (beta = -0.112, p=0.022), serum uric acid (SUA) (beta = -0.425, p<0.001) and the presence of extra-articular disease, apart from sicca and/or nodules (beta = -0.084, p=0.040).
CONCLUSIONS: Renal dysfunction in RA is quite common and associates with classic cardiovascular risk factors such as advanced age and dyslipidaemia, levels of SUA and the presence of extra-articular disease. Renal dysfunction was not related to other RA-related factors including disease activity and duration, disability and past or present use of nephrotoxic medications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279016     DOI: 10.1136/ard.2008.105049

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

Review 1.  Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps.

Authors:  Thomas Zegkos; George Kitas; Theodoros Dimitroulas
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-04-30       Impact factor: 5.346

2.  Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation.

Authors:  Dimitrios Daoussis; Vasileios F Panoulas; Holly John; Tracey E Toms; Ioannis Antonopoulos; Gareth Treharne; Peter Nightingale; Karen M J Douglas; George D Kitas
Journal:  Clin Rheumatol       Date:  2010-04-16       Impact factor: 2.980

3.  Modulation of autoimmune arthritis severity in mice by apolipoprotein E (ApoE) and cholesterol.

Authors:  P Alvarez; F Genre; M Iglesias; J J Augustin; E Tamayo; J C Escolà-Gil; B Lavín; F Blanco-Vaca; R Merino; J Merino
Journal:  Clin Exp Immunol       Date:  2016-10-04       Impact factor: 4.330

4.  Development of reduced kidney function in rheumatoid arthritis.

Authors:  LaTonya J Hickson; Cynthia S Crowson; Sherine E Gabriel; James T McCarthy; Eric L Matteson
Journal:  Am J Kidney Dis       Date:  2013-10-04       Impact factor: 8.860

5.  Tc-99 m diethylenetriamine-pentaacetic acid (DTPA): is it reliable for assessment of methotrexate-induced cumulative effect on renal filtration in rheumatoid arthritis patients?

Authors:  Amr Amin; Dina Effat; Nabila Goher; Basma Ramadan
Journal:  Rheumatol Int       Date:  2012-12-23       Impact factor: 2.631

6.  Spectrum and prognosis of renal histopathological lesions in 56 Chinese patients with rheumatoid arthritis with renal involvement.

Authors:  Ti Zhang; Shaoshan Liang; Xiaopian Feng; Manna Li; Houan Zhou; Caihong Zeng; Jiong Zhang; Zhen Cheng
Journal:  Clin Exp Med       Date:  2020-02-11       Impact factor: 3.984

7.  Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications - A National Population-Based Cohort Study.

Authors:  Hsien-Yi Chiu; Hui-Ling Huang; Chien-Hsun Li; Hung-An Chen; Chia-Lun Yeh; Shih-Hsiang Chiu; Wei-Chun Lin; Yu-Pin Cheng; Tsen-Fang Tsai; Shinn-Ying Ho
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

8.  Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis.

Authors:  Dimitrios Daoussis; Vasileios Panoulas; Tracey Toms; Holly John; Ioannis Antonopoulos; Peter Nightingale; Karen M J Douglas; Rainer Klocke; George D Kitas
Journal:  Arthritis Res Ther       Date:  2009-07-24       Impact factor: 5.156

9.  Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals.

Authors:  Shunsuke Mori; Tamami Yoshitama; Naoyuki Hirakata; Yukitaka Ueki
Journal:  Clin Rheumatol       Date:  2017-09-07       Impact factor: 2.980

10.  Impaired renal functions in Pakistani cohort of rheumatoid arthritis.

Authors:  Abrar Ahmed Wagan; Sadia Nasir; Abdul Rahim; Daim Khan
Journal:  Pak J Med Sci       Date:  2019 Jul-Aug       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.